Tweetable abstract Mitochondria are increasingly a target for drug delivery in cardiovascular diseases. This editorial describes how a nanomedicine approach may improve drug potency and efficacy in a safe and controlled manner.
Journal article
2023-12-01T00:00:00+00:00
18
2101 - 2104
3
adenosine triphosphate, heart failure, ischemia/reperfusion injury, mitochondria, nanoparticles, reactive oxygen species, Nanomedicine, Nanoparticles, Drug Delivery Systems, Heart, Mitochondria